Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion
Open Access
- 10 April 2006
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 203 (4), 1105-1116
- https://doi.org/10.1084/jem.20051615
Abstract
Type 2 immunity, which involves coordinated regulation of innate and adaptive immune responses, can protect against helminth parasite infection, but may lead to allergy and asthma after inappropriate activation. We demonstrate that il25(-/-) mice display inefficient Nippostrongylus brasiliensis expulsion and delayed cytokine production by T helper 2 cells. We further establish a key role for interleukin (IL)-25 in regulating a novel population of IL-4-, IL-5-, IL-13-producing non-B/non-T (NBNT), c-kit+, FcepsilonR1- cells during helminth infection. A deficit in this population in il25(-/-) mice correlates with inefficient N. brasiliensis expulsion. In contrast, administration of recombinant IL-25 in vivo induces the appearance of NBNT, c-kit+, FcepsilonR1- cells and leads to rapid worm expulsion that is T and B cell independent, but type 2 cytokine dependent. We demonstrate that these IL-25-regulated cells appear rapidly in the draining lymph nodes, implicating them as a source of type 2 cytokines during initiation of worm expulsion.This publication has 45 references indexed in Scilit:
- Basophils Initiate IL-4 Production during a Memory T-dependent ResponseThe Journal of Experimental Medicine, 2004
- Basophils Produce IL-4 and Accumulate in Tissues after Infection with a Th2-inducing ParasiteThe Journal of Experimental Medicine, 2004
- Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 ReporterImmunity, 2001
- Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosisMultiple Sclerosis Journal, 1999
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsThe Journal of Experimental Medicine, 1997
- Activated mast cells produce interleukin 13.The Journal of Experimental Medicine, 1995
- CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.The Journal of Experimental Medicine, 1994
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992
- Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells.The Journal of Experimental Medicine, 1990